ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,114.63
-0.01%
US Tech 100
21,524.40
0.41%
다우존스 지수
44,546.08
-0.37%
Bitcoin
97,314.59
-0.29%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. NovoCure Ltd (NVCR) 시세

NovoCure Ltd

NovoCure Ltd (NVCR)

NASDAQ
22.48
0.77
(3.55%)
마감 16 2월 6:00AM
15분 지연
22.48
0.00
(0.00%)
시간외 거래: 8:31AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
22.48
매수가
21.94
매도가
22.62
거래량
740,179
21.72 일간 변동폭 22.95
11.70 52주 범위 34.13
market_cap
2.432B
전일 종가
21.71
개장가
21.84
최근 거래 시간
5
@
22.45
마지막 거래 시간
재정 규모
US$ 16,657,431
VWAP
22.5046
평균 볼륨(3m)
1,229,329
발행 주식
108,201,434
배당수익률
-
주가수익률
-11.75
주당순이익(EPS)
-1.91
매출
509.34M
순이익
-207.04M

NovoCure Ltd 정보

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives it... NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States. 더 보기

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
www.novocure.com
본부
Jersey, Gbr
설립됨
-
NovoCure Ltd is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker NVCR. The last closing price for NovoCure was US$21.71. Over the last year, NovoCure shares have traded in a share price range of US$ 11.70 to US$ 34.13.

NovoCure currently has 108,201,434 shares in issue. The market capitalisation of NovoCure is US$2.35 billion. NovoCure has a price to earnings ratio (PE ratio) of -11.75.

NVCR 최신 뉴스

추가 뉴스

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
16 1월 2025
NVCR (3.55%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
14 1월 2025
NVCR (3.55%)

Form 8-K - Current report
Edgar (US Regulatory)
13 1월 2025
NVCR (3.55%)

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
07 1월 2025
NVCR (3.55%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.33-1.4467338886522.8123.1820.71571639921.64212263CS
4-3.18-12.392829306325.6627.4720.71575871024.23846154CS
125.2930.773705642817.1934.1317.16122932927.91178324CS
264.0922.240348015218.3934.1314.17111837622.23653335CS
527.2447.506561679815.2434.1311.7125755519.5232072CS
156-55.31-71.101684021177.79120.0310.87110051436.72778114CS
260-70.95-75.939205822593.43232.7610.87100920765.7475729CS

NVCR - Frequently Asked Questions (FAQ)

What is the current NovoCure share price?
The current share price of NovoCure is US$ 22.48
How many NovoCure shares are in issue?
NovoCure has 108,201,434 shares in issue
What is the market cap of NovoCure?
The market capitalisation of NovoCure is USD 2.35B
What is the 1 year trading range for NovoCure share price?
NovoCure has traded in the range of US$ 11.70 to US$ 34.13 during the past year
What is the PE ratio of NovoCure?
The price to earnings ratio of NovoCure is -11.75
What is the cash to sales ratio of NovoCure?
The cash to sales ratio of NovoCure is 4.78
What is the reporting currency for NovoCure?
NovoCure reports financial results in USD
What is the latest annual turnover for NovoCure?
The latest annual turnover of NovoCure is USD 509.34M
What is the latest annual profit for NovoCure?
The latest annual profit of NovoCure is USD -207.04M
What is the registered address of NovoCure?
The registered address for NovoCure is NO 4 THE FORUM, GRENVILLE STREET, ST. HELIER, JERSEY, JE2 4UF
What is the NovoCure website address?
The website address for NovoCure is www.novocure.com
Which industry sector does NovoCure operate in?
NovoCure operates in the SURGICAL,MED INSTR,APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
JTAIJet AI Inc
US$ 6.02
(133.33%)
104.48M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
WRDWeRide Inc
US$ 31.4877
(83.39%)
21.07M
INLFINLIF Limited
US$ 16.27
(80.58%)
7.68M
MBRXMoleculin Biotech Inc
US$ 2.1201
(66.94%)
136.66M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3.08
(-56.31%)
425.19k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3.36
(-52.68%)
5.21k
CSAICloudastructure Inc
US$ 19.0001
(-49.58%)
1.01M
NEXNNexxen International Ltd
US$ 10.30
(-49.16%)
160.99k
BSLKBolt Projects Holdings Inc
US$ 0.6626
(-46.13%)
13.07M
CNSPCNS Pharmaceuticals Inc
US$ 0.1415
(31.26%)
489.28M
MGOLMGO Global Inc
US$ 0.7176
(-15.08%)
417.31M
SRMSRM Entertainment Inc
US$ 0.6999
(95.50%)
254.39M
INTCIntel Corporation
US$ 23.60
(-2.20%)
230.26M
NVDANVIDIA Corporation
US$ 138.85
(2.63%)
194.99M

NVCR Discussion

게시물 보기
jondoeuk jondoeuk 1 월 전
KEYNOTE-D58 is a pivotal trial (N=741) of Optune concomitant with temozolomide plus keytruda in ndGBM. The estimated primary completion date is April 2029.
👍️0
jondoeuk jondoeuk 1 월 전
Data from the PhII 2-THE-TOP trial https://www.onclive.com/view/temozolomide-pembrolizumab-plus-ttfields-leads-to-tumor-control-in-newly-diagnosed-glioblastoma
👍️0
KIPK KIPK 1 월 전
dennisbabe - You are not smart enough to be impactful one way or another..
You are just one irrelevant poster.....
👍️0
KIPK KIPK 1 월 전
LOL - Garbage post....
👍️0
PonkenPlonken PonkenPlonken 1 월 전
thank you very much for sharing jondoeuk!
👍️0
jondoeuk jondoeuk 1 월 전
It is a pilot trial, but mPDAC is the largest category at diagnosis. Depending on the data (and if a pivotal trial ends up being successful), TTFs could eventually be used across all diagnosis categories.
👍️0
whosleftholdindabag whosleftholdindabag 2 월 전
Wishing a Happy New Year to everyone who is invested in $NVCR!
👍️0
KIPK KIPK 2 월 전
dennisdave, you & FeMike are made for each other. The two Irrelevant Scam Artistwannabies, begging for attention..

You are both piles of SSSSSSSSSSSSS.......HIT....
👍️0
KIPK KIPK 2 월 전
And you jondickuk, crawling around to save your clients from bad advise you capable of giving..

LOL....
👍️0
whosleftholdindabag whosleftholdindabag 2 월 전
$NVCR has reached its 52-week high! Wishing everyone a great weekend! GLTA
👍️0
PonkenPlonken PonkenPlonken 2 월 전
Thank you for sharing!
They seem to believe this makes it to market in CRC is my read.
👍️0
jondoeuk jondoeuk 2 월 전
A phase 2 trial, PANOVA-4, will test TTFields combined with a triplet regimen of gemcitabine, nab-paclitaxel and atezolizumab as a first-line treatment for metastatic pancreatic ductal adenocarcinoma. It has completed enrolment and the company said it expects to have data in 2026.

The primary endpoint is disease control rate (DCR). Secondary endpoints include, overall survival (OS), progression-free survival (PFS), 1-year OS rate, objective response rate (ORR), PFS at 6 months, duration of response, and safety.
👍️0
whosleftholdindabag whosleftholdindabag 2 월 전
$NVCR what a great way to kick off December, don't you know? Where are all the bloody naysayers today? We're raising a lot of money for charity! GLTA
👍️0
jondoeuk jondoeuk 2 월 전
Novocure plans to file for regulatory approval in the U.S., EU, Japan and other key markets; Zai Lab plans to file for regulatory approval in China https://www.businesswire.com/news/home/20241202363277/en/Zai-Lab-and-Novocure-Announce-Positive-Topline-Results-from-Phase-3-PANOVA-3-Clinical-Trial-of-Tumor-Treating-Fields-TTFields-Therapy-for-Pancreatic-Cancer
👍️ 1
tw0122 tw0122 2 월 전
Looking good $30 +
50% 
12:09 PM EST, 12/02/2024 (MT Newswires) -- (Updates with stock move in the headline and first paragraph.)NovoCure's (NVCR) shares rose more than 41% in recent Monday trading after the company and Zai Lab (ZLAB) said that their phase 3 trial evaluating TTFields along with gemcitabine and nab-paclitaxel as a treatment for unresectable, locally advanced pancreatic adenocarcinoma achieved its primary endpoint, demonstrating a "statistically significant" improvement in median overall survival.NovoCure (NVCR) plans regulatory filings in the US, EU, Japan, and other major markets, while Zai Lab plans to file for regulatory approval in China, the companies said.
👍️0
PonkenPlonken PonkenPlonken 2 월 전
would love to see new session high
data is hot --- Can become SOC
👍️0
whosleftholdindabag whosleftholdindabag 3 월 전
$NVCR back above $20! GLTA
👍️0
Invest-in-America Invest-in-America 4 월 전
NVCR: One has to be patently BRAIN DEAD to attribute any significance whatsoever to the 1890's-like ELECTRICAL, cure-all, gadgets that this obvious SCAM company promotes!!!
👍️ 1
jondoeuk jondoeuk 4 월 전
FDA Approves Novocure’s Optune Lua for the Treatment of Metastatic Non-Small Cell Lung Cancer https://www.businesswire.com/news/home/20241015381082/en
👍️ 1 💥 1
whosleftholdindabag whosleftholdindabag 4 월 전
Lovely action AH $NVCR! I can't wait for the opening bell, wishing everyone a great evening! GLTA
👍️0
whosleftholdindabag whosleftholdindabag 4 월 전
$NVCR great way to end the trading day! GLTA
👍️0
whosleftholdindabag whosleftholdindabag 4 월 전
I own both $NVCR and $NWBO, all proceeds will go to charity. GLTA
👍️0
KIPK KIPK 4 월 전
Glad to see you are in the right stock, NWBO, now!!
👍️0
TiltMyBrain TiltMyBrain 5 월 전
Who is the bag holder now???

Going to single digits
👍️ 1
whosleftholdindabag whosleftholdindabag 7 월 전
Come fly with me, let's fly let's fly away! Ol blue eyes, what a beautiful voice! Great start $NVCR! GLTA
🚽 1
whosleftholdindabag whosleftholdindabag 7 월 전
Back above $20 $NVCR! GLTA
👍️0
whosleftholdindabag whosleftholdindabag 8 월 전
Another week, another beautiful day for $NVCR shareholders! GLTA
🐀 1
whosleftholdindabag whosleftholdindabag 9 월 전
Another beautiful start of the week for $NVCR! GLTA
👍️0
KIPK KIPK 9 월 전
LOL - Go from over $200 to $20.
Wondering why this charity worker is NWBO hater.
Wondering why a self proclaimed good spirit tries so hard to destroy a great cancer therapy company. NWBO, hat is not NVCR??
A true charity worker expected to be compassionate, caring, and greatful of all possible potentials...

BUT not this guy??

You judge!!!

KARMA!!
👍️ 3 💯 2
whosleftholdindabag whosleftholdindabag 9 월 전
GO $NVCR GO! We're making A LOT of $$$$$ for charities don't you know? GLTA
⚠️ 1
whosleftholdindabag whosleftholdindabag 9 월 전
Beautiful day $NVCR! GLTA
👎️ 1 🤣 2
whosleftholdindabag whosleftholdindabag 9 월 전
It's been another great week for $NVCR! Have a wonderful weekend everyone! GLTA
👎️ 1 🚫 1 🤣 1
TiltMyBrain TiltMyBrain 9 월 전
Insiders to sell shares in 30 days
👍️ 2 💥 2
KIPK KIPK 9 월 전
LOL 🤣🤣🤣
👍️ 1 💯 1
dstock07734 dstock07734 9 월 전
Or you can simply wait.
👍️ 1 🤣 2
whosleftholdindabag whosleftholdindabag 9 월 전
Well that's fantastic mate! Perhaps I'll have my lawyer contact her, have a great weekend! GLTA
🤣 1 ⚠️ 1
dstock07734 dstock07734 9 월 전
By now, you should be smart enough to know that Laura Posner or Elliott Leary would be able to get IP address of each poster on NWBO board.
👍️ 3
dstock07734 dstock07734 9 월 전
libel? Which part is libel? Nemesis18's post style is very similar to yours, would you agree?
👍️ 3 🤣 2
whosleftholdindabag whosleftholdindabag 9 월 전
No, do you? GLTA
⚠️ 1
whosleftholdindabag whosleftholdindabag 9 월 전
I'd be careful you're getting a wee bit close to libel don't you know? GLTA
🚫 1 🤣 1
whosleftholdindabag whosleftholdindabag 9 월 전
Great way to end the week! Finish strong $NVCR! Have a great weekend everyone! GLTA
🚫 1 🤣 1
whosleftholdindabag whosleftholdindabag 9 월 전
You're posting on the wrong board mate, $NWBO is the one dealing with toxic financers go over there and post your rubbish! GLTA

Streeterville Capital, LLC is a Chicago-based company owned by John M. Fife, who has been described as a "toxic lender" for many years. Toxic financing is a type of financing that companies use when they are in poor condition and can't get financing in any other way. It can come in the form of convertible debt or convertible preferred stock and often gives the debtholder an unlimited number of common shares when they convert their debt or preferred shares to common stock.
👍️ 1
TiltMyBrain TiltMyBrain 10 월 전
Toxic financing for a company who’s price is down 90% in last 3 years
👍️ 2 💥 2
TiltMyBrain TiltMyBrain 10 월 전
Today is the pump. Tomorrow is the insider dump
👍️ 2 💥 2
KIPK KIPK 10 월 전
What a great day right Nemeses 18?
How is dat charity holding da bag???
👍️ 1 😂 2 🤣 1
KIPK KIPK 10 월 전
Gone with the wind on wings of fake therapy IMO
👍️ 1 💯 1
KIPK KIPK 10 월 전
20? including a PRE-CLINICAL???? lol
And all that unfocused activity signal the total desperation to keep the SP up IMO...

Reminds me of INO, which also kept throwing stuff at every possible thing, hoping one would stick.... But NO... INO SP at one time was over $2000 & now is around $11 after a recent RS
👍️0
axelvento axelvento 10 월 전
Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

https://www.biospace.com/article/releases/novocure-announces-20-presentations-on-tumor-treating-fields-highlighting-preclinical-effects-in-pancreatic-cancer-and-immune-effects-at-american-association-for-cancer-research-aacr-annual-meeting-2024/
👎️ 2 🤣 1
TiltMyBrain TiltMyBrain 11 월 전
https://x.com/peter_brit/status/1775041789889491437?s=46&t=1nHn7IXseo2gJ7ymtRCgUA

This ship is sinking fast!
👍️ 3 👏 3
TiltMyBrain TiltMyBrain 11 월 전
insider selling in 3...2...1...
👍️ 3 💯 3 😂 1 🤣 1

최근 히스토리

NASDAQ
NVCR
NovoCure
USOTC
RVSDF
Riverside Res (QB)
LSE
0VRA
Zkb Platinum Etf Aa Chf
FX
JPYRUB
Yen vs RUB
TG
ANI0
Amundi PEA MSCI USA Value
COIN
MPGGUSD
MedPing
AQSE
LEND.GB
Sancus Lending
DOWI
DJSE40
DJ Sustainability Europe...
TSX
CPI
Condor Petroleum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지